BeiGene

BeiGene

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at BeiGene. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
1,937 people
Headquarters
Cambridge, MA +21 more
Founded
2010
Type
Public Company
Total funding
$6.8B

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.

targeted therapy immuno-oncology hematology oncology and cancer

Open roles at BeiGene